Das humane Papillomavirus (HPV) in der Gynäkoonkologie

Knowledge concerning the human papillomavirus in the development of cervical cancer and other genital cancers has led to a rethinking and therefore renewal of primary prevention. In addition to the annually offered cytological check for preventing cervical cancer, a vaccination has also been developed which targets adolescent girls. Current results of clinical trials are positive but long-term follow-up results are still awaited. The second pillar of the prevention of cervical cancer is the annual cytological check up. Unfortunately, only the minority of women in Germany undergo this check. Therefore it remains questionable whether the new vaccination strategy is able to close this gap and reduce the incidence of cervical cancer.